Trial intelligence / Profile preview

Acetaminophen and Ibuprofen +/- Magnesium for Pediatric Migraine

NCT01756209Phase 4Completed

Sponsor
University of Magna Graecia
Start
Jan 2010
Primary completion
Feb 2012
Modality
Orthosteric Ligands
Countries
1
01

Overview

Phase 4, randomised, single-blind trial of magnesium in migraine (4 arms), sponsored by University of Magna Graecia. Primary endpoint: Pain-relief at 18 months. Started Jan 2010; status: completed.

02

Drugs

magnesium
03

Conditions

migraine

Beyond the preview

Go deeper on NCT01756209.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01756209.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call